Bioventus  logo

Bioventus BVS

$ 11.31 -2.42%

Quarterly report 2024-Q3
added 11-05-2024

report update icon

Country

usaUSA

IPO year

2021

Industry

Diagnostics research

Stock Exchange

NASDAQ GLOBAL

CEO

Dr. Henry C. Tung

Employees in the company

-

Shares

62.6 M

Market Cap[1]

$ 709 M

EBITDA (LTM)

$ 682 K

P/E (LTM)

-17.92

P/S (LTM)

1.31

EPS (LTM)

-0.63

Other stocks of industry "Diagnostics research"

References

  1. Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.